Revolution Medicines

700 Saginaw Drive
Redwood City
United States

Tel: (650) 481-6801


Show jobs for this employer

About Revolution Medicines

REVOLUTION Medicines discovers and develops important new medicines for cancer patients by translating frontier oncology targets – proteins that drive the growth of cancers or that control immune responses that can defeat them. The company has a robust pipeline of R&D programs focused on frontier targets, including SHP2 (PTPN11), a tyrosine phosphatase enzyme that regulates cancer growth signaling and the immune response, SHP1 (PTPN6), a second tyrosine phosphatase that regulates multiple arms of the immune response, and 4EBP1, a key regulator of oncogene translation in the PI3K/AKT/mTOR pathway.

Headquartered in Redwood City, Calif. at the intersection of Silicon Valley and the birthplace of biotechnology, REVOLUTION Medicines is a private company financed by top-tier investors through $126 million raised in Preferred Series A & B rounds.

16 articles with Revolution Medicines